Lab to Impact: Building Bridges — Bringing Life Sciences Technologies to Market Through Business Development

This Lab to Impact session will explore the strategic role of business development and partnering in advancing life sciences innovation from academia to industry. Through a moderated discussion, we will compare how venture capital, biotech companies, and pharmaceutical organizations evaluate academic technologies, define partnership objectives, and engage in collaboration. Hosted by Jamie Brisbois, Manager of Business Development and Licensing at CTL at Weill Cornell Medicine.

Register here.